Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
United Therapeutics Corporation UTHR today announced its financial results for the first quarter ended March 31, 2013.
“I am pleased that our first quarter 2013 results were solid, providing a strong foundation for continued growth,” said Martine Rothblatt, Ph.D., United Therapeutics’ Chairman and Chief Executive Officer. “Our pipeline continues to grow, with two phase 3 trials, a new phase 1 trial of mesenchymal stem cells in PAH patients and advances in our strategic product portfolio.”
Help employers find you! Check out all the jobs and post your resume.
